Vascular Effects of Hesperidin in Metabolic Syndrome

NCT00914251 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Endothelial Dysfunction
Metabolic Syndrome

Interventions

DRUG: Hesperidin
DRUG: Placebo

Sponsor

University of Rome Tor Vergata